The Hellenic Society for Chemotherapy was founded in Athens, in 1969, by 28 distinguished Greek physicians, surgeons and microbiologists. The HSC is a non-profit organization whose mission is to advance the Greek Medical Sciences in the field of chemotherapy. This is achieved: a) by promoting and supporting research, education and training, and b) by organizing national international congresses, in collaboration with local or foreign scientific societies, of similar targets. The HSC is an affiliated member of the ISC and of ESCMID. Nowadays, HSC claims 222 active members.
Honorary President: Prof. Emeritus: George Daikos.
The Executive Committee consists of the President (Prof. Helen Giamarellou), the Vice President (Prof. Charalambos Gogos), Secretary General, (Prof. Kiriaki Kanellakopoulou), the Secretary Assistant Prof. George Daikos), the Treasurer (Dr. Angelos Pefanis), two additional members (Prof. Christina Routsi, and Dr. Garifalia Poulakou) and a co-opted member (Dr. Athina Argyropoulou)
In 1985, the HSC founded the Amphiaraeion Foundation of Chemotherapeutic Studies (AFCS), a non-profit foundation, which is the supervision of the Hellenic Ministries of Education and Finance. AFCS engaged in advancing scientific knowledge in Medicine, scholarship awards and financial aid to young doctors. It has awarded numerous scholarships for postgraduate studies in Greece and abroad, cash prizes for research studies in the field of Infectious Diseases, and financial aids to young doctors, to continue their postgraduate studies.
HSC founded and supports four study groups:
• The Sepsis Study Group (Founder member of the Global Sepsis Alliance)
• The Infective Endocarditis Study Group
• The Study Group for Bone Infections / The Bone Infection Study Group
• The Study Group for ICU Infections / The ICU Infections Study Group
The HSC has organized 24 educational courses and workshops on Antimicrobial Resistance. Invited speakers, among others, were eminent scientists from Greece, USA (Prof. G. Eliopoulos), UK (Prof. JD. Williams), Holland (Prof. vanDerMeer), Spain (Prof. X. Garau), Italy (Prof. G. Cornaglia, and JM. Rossolini).
The following Congresses, Conferences and Courses have been organized by the HSC:
• 8th International Congress of Chemotherapy, Athens, 1973 (1000 participants)
• 4th Mediterranean Congress of Chemotherapy, Rhodes, Greece, 1984 (3500
• 1st Hellenic-British-Scandinavian Congress of Antimicrobial Chemotherapy, Athens,
• 2ed Hellenic-British-Scandinavian Congress of Antimicrobial Chemotherapy,
Sithonia, Greece, 1989
• 8th Mediterranean Congress of Chemotherapy, Athens, 1992 (3000 participants)
• 4th Hellenic-British-Scandinavian Congress of Antimicrobial Chemotherapy,
Limasol, Cyprus, 1993
The most recent conferences and educational courses organized by the Hellenic Sepsis Study Group of the HSC were:
• 4th European Conference on Bloodstream Infections, Athens GR, May 2010
• 5th European Conference on Bloodstream Infections, Limassol CY, November 2012
• ESCMID Course: «Hot topics in the critically ill patient», Athens GR, June 2013
• 6th European Conference on Bloodstream Infections, Vravrona GR, June 2015
In the context of Continuing Medical Education, HSC organized in Athens and in major other cities in Greece, 20 interactive educational courses for hospital physicians a project focusing on Rational Antimicrobial Chemotherapy. Moreover, in collaboration with the Greek Medical Association the HSC has organized all over the country 50 informative meetings for the public, regarding the prudent use of antibiotics in the community, as well as on the indication of vaccines. In addition, the HSC organizes annual workshops on rational antimicrobial chemotherapy in collaboration with the Hellenic Society for Infectious Diseases and the Medical Society of Athens.
Currently the HSC in cooperation with the Hellenic Center for Disease Control and Prevention (HCDCP) aiming to reduce the inappropriate consumption of antibiotic in upper respiratory tract infections, is performing a study regarding the application of the Rapid Antigen Test by the GPs in several parts of Greece.
International scientific publications:
Α) By the sepsis study group: 16 publications on a variety of sepsis topics
B) By the ICU Infection Study Group:
1. Epidemiological study on fungemias and bacteremias in 12 Greek ICUs: 2012-2014 - at ECCMID 2015, Copenhagen: EV0102: “Multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae bloodstream infections in intensive care unit patients: epidemiology and outcomes”, EV0103“: Epidemiological features of XDR and PDR Acinetobacter baumannii bacteraemia from Greek ICUs: preliminary results from a multicentre registry”
2. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int J Antimicrob Agents 2014; 43: 52-9
C) Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013. Infect Dis (Lond). 2015 Dec 4:1-6.